Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07025772 · ClinicalTrials.gov registry record · NA

Shaping Habitual Impulses For a Tobacco-free Style

A NA study, sponsored by University of Houston.

Recruiting
Registry status
NA
Development phase
300
Enrollment target

NCT07025772: Recruiting NA study, sponsored by University of Houston.

NCT07025772 is a NA study that is actively recruiting participants, run by University of Houston. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07025772, a NA study, is actively recruiting participants, sponsored by University of Houston.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target

Study Summary

The present investigation aims to assess the efficacy of an innovative and novel smoking cessation intervention that integrates approach bias retraining (ABR) and standard smoking cessation treatment (ST). Participants will be randomized to either: (1) standard smoking cessation treatment and approach bias retraining (ST+ABR); (2) ST+Sham; or (3) ST-only.

Primary Outcome

PPA will be defined as no cigarette smoking within the past 7 days of assessments and will be biochemically verified via assessment of expired carbon monoxide.

Interventions

  • BEHAVIORAL ST+ABR
  • BEHAVIORAL ST+Sham
  • BEHAVIORAL ST Only

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2026-03-24
Est. Completion 2029-02-01
Phase NA
University of Houston

64 total trials

What NCT07025772 shows while recruiting

NCT07025772 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 3 interventions - of which ST+ABR is the first listed.

NCT07025772 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07025772 about?

NCT07025772 is a clinical study titled "Shaping Habitual Impulses For a Tobacco-free Style". The present investigation aims to assess the efficacy of an innovative and novel smoking cessation intervention that integrates approach bias retraining (ABR) and standard smoking cessation treatment (ST). Participants will be randomized to either: (1) standard smoking cessation treatment and approa...

What is the current status of trial NCT07025772?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2026-03-24. Estimated completion is 2029-02-01.

What interventions are being tested in trial NCT07025772?

The interventions under investigation include: ST+ABR (BEHAVIORAL), ST+Sham (BEHAVIORAL), ST Only (BEHAVIORAL).

Who is sponsoring clinical trial NCT07025772?

This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07025772's enrollment target sits among peer trials

300 330th of 2000 higher than 1,630 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07025772, the US trial registry maintained by the National Library of Medicine. NCT07025772 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.